USANA Health Sciences Inc. said its normalized net income for the fiscal first quarter ended April 4 amounted to 72 cents per share, compared with the S&P Capital IQ consensus estimate of 65 cents per share.
EPS rose 30.5% year over year from 55 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $18.7 million, a gain of 18.6% from $15.8 million in the first quarter ended March 29, 2014.
The normalized profit margin declined to 8.5% from 8.7% in the year-earlier period.
Total revenue rose 20.3% on an annual basis to $219.4 million from $182.4 million, and total operating expenses grew 20.5% from the prior-year period to $189.6 million from $157.3 million.
Reported net income grew 18.6% from the prior-year period to $19.6 million, or 75 cents per share, from $16.6 million, or 57 cents per share.
